Philippe M.
- Country
- France
- Department
- Radiotherapy
Research Overview
- Phase II Randomized Trial of Atezolizumab with Chemoradiotherapy in Locally Advanced Cervical Cancer
- Phase III Randomized Trial of Radiotherapy with Cisplatin Versus Radiotherapy Alone in Sinus and Salivary Gland Tumors
- Phase II Evaluation of Durvalumab Combined with Radiotherapy in T1-T4 N0-N2b Squamous Cell Carcinoma of the Head and Neck Without Prophylactic Neck Irradiation
Data & Insights
Has run more than one trial at 14 of 79 partner sites.
Specializations
Cervical Cancer Research
Focused on advancing treatment approaches for locally advanced cervical cancer, particularly investigating innovative combinations of immunotherapy with standard treatment protocols.
- Chemoradiotherapy Integration
- Immune Checkpoint Inhibition
- Disease Progression Assessment
Explores therapeutic strategies combining standard care with novel immunological approaches.
Head and Neck Oncology
Specializes in treating various forms of head and neck squamous cell carcinoma, with particular attention to oropharyngeal, laryngeal, and hypopharyngeal cancers.
- Targeted Radiotherapy Approaches
- Novel Drug Combinations
- Treatment of Elderly Patients
Investigates optimized treatment protocols for different patient populations.
Specialized Cancer Treatment
Expert in treating sinonasal and salivary gland tumors, developing therapeutic approaches for both resectable and non-resectable cases.
- Post-Surgical Therapy
- Radiotherapy Optimization
- Multi-Modal Treatment Strategies
Focuses on comparing and evaluating different treatment modalities for optimal patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.